With support from the Food Standards Agency and the Biotechnology and Biological Sciences Research Council they are investigating whether diet could control these changes and delay or reverse the onset of cancer.
“We looked at changes in 18 genes that play a role in the very earliest stages of colorectal cancer,” says Professor Ian Johnson at the Institute of Food Research.
“We detected clear chemical differences in these genes in otherwise normal tissue in cancer patients.
“This represents a new way to identify defects that could eventually lead to cancer.”
All cells carry a complete set of instructions for the whole organism in their nuclear DNA, but to define the specialised structure and functions of each particular cell type, genes must be switched on or firmly off, over the course of the cell’s life-cycle.
One of the mechanisms controlling the activities of the genes in a cell is the “epigenetic code”, a set of chemical tags attached to the DNA molecule, marking individual genes for expression, or for silence. It is well known that the abnormal behaviour of cancer cells is partly due to mistakes in this epigenetic code, some of which switch on genes for growth, whilst others switch off genes that would otherwise cause abnormal cells to destroy themselves.
Scientists at IFR are exploring the possibility that such mistakes in the epigenetic code may begin to occur in apparently normal tissues, long before the appearance of a tumour.
In the current study published in the British Journal of Cancer they measured the numbers of methyl groups attached to DNA taken from the cells lining the large intestine of bowel cancer patients. They found subtle changes that may make the whole surface of the bowel more vulnerable to the eventual development of tumours by causing the ‘addiction’ of cells to abnormal gene expression.
Some of these changes seem to occur naturally with age, but, supported by the Food Standards Agency, IFR is investigating the possibility that factors in our lifestyle such as diet, obesity and exercise can accelerate or delay DNA methylation as we grow older, thus giving us some degree of control over this vital aspect of our long-term health.
Professor Nigel Brown, Director of Science and Technology at BBSRC said: “Basic research in the relatively young field of epigenetics is already contributing to our understanding of human health. Understanding how epigenetic processes work to maintain healthy cells and tissues is the key to long-term health because, as we see here, the breakdown of these normal processes may subsequently cause disease. BBSRC funds a range of research in the field of epigenetics and has been encouraging networking amongst members of the European epigenetics research community.”
Contacts
Zoe Dunford, Media Manager, Institute of Food Research
t: 01603 255111
m: 07768 164185
e: zoe.dunford@bbsrc.ac.uk
Andy Chapple, Press Office Assistant, Institute of Food Research
t: 01603 251490
m: 07785 766779
e: andrew.chapple@bbsrc.ac.uk
Zoe Dunford | Source: alphagalileo
Further information: www.bbsrc.ac.uk
www.bjcancer.com
Further Reports about: DNA > epigenetic > tumour
More articles from Life Sciences:
First reconstitution of an epidermis from human embryonic stem cells
23.11.2009 | INSERM (Institut national de la santé et de la recherche médicale)
Causative gene of a rare disorder discovered by sequencing only protein-coding regions of genome
23.11.2009 | University of Washington
UCSB physicists move 1 step closer to quantum computing
23.11.2009 | Physics and Astronomy
Fat around the middle increases the risk of dementia
23.11.2009 | Studies and Analyses
New discovery about the formation of new brain cells
23.11.2009 | Health and Medicine
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News